Marks Believes Trump Team Will Not Threaten US FDA’s Medicines Expertise

 
• By Andrew McConaghie
  
CBER Director Peter Marks said he was not worried about rhetoric and that the FDA's high standards would be preserved. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Elections

More from Legislation